Progress in contraception: new technology
- PMID: 13677551
Progress in contraception: new technology
Abstract
Unintended pregnancy continues to be a major public health issue in this country. Approximately 50% of pregnancies in the United States are unintended, and, of these, half end in abortion. Although tubal sterilization is highly effective, many women subsequently express regret and remorse. Oral contraceptives represent an effective, reversible method. However, many women have difficulty using them consistently and correctly. Recently, four new delivery systems for hormonal contraception have become available in the United States: the monthly injection, the levonorgestrel intrauterine system, the combination hormonal contraceptive vaginal ring, and the transdermal contraceptive patch. All four new methods are effective, readily reversible, generally discreet, and reduce daily compliance challenges. The monthly injection, vaginal ring, and transdermal patch can be discontinued without the need for an office visit. This expanded menu of effective contraceptive options should help women find a method that suits their particular life style.
Similar articles
-
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.J Fam Pract. 2004 Nov;53(11):904-13. J Fam Pract. 2004. PMID: 15527729 Review. No abstract available.
-
Comparing patient telephone callback rates for different hormonal birth control delivery systems.Am J Ther. 2006 Nov-Dec;13(6):507-12. doi: 10.1097/01.mjt.0000212893.28081.b8. Am J Ther. 2006. PMID: 17122531 Clinical Trial.
-
Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.J Reprod Med. 2003 Jul;48(7):525-40. J Reprod Med. 2003. PMID: 12953327 Review.
-
Newer non-oral hormonal contraception.BMJ. 2013 Feb 14;346:f341. doi: 10.1136/bmj.f341. BMJ. 2013. PMID: 23412438 No abstract available.
-
Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.Prescrire Int. 2004 Aug;13(72):123-6. Prescrire Int. 2004. PMID: 15532134